Clinical trial
ReoPro and Retavase to Treat Acute Stroke
NCT00046293 · National Institute of Neurological Disorders and Stroke (NINDS), NIH · Completed
Key facts
| NCT number | NCT00046293 |
|---|---|
| Title | ReoPro and Retavase to Treat Acute Stroke |
| Official title | ReoPro Retavase Reperfusion of Stroke Safety Study-Imaging Evaluation With Computed Tomography (ROSIE-CT) |
| Lead sponsor | National Institute of Neurological Disorders and Stroke (NINDS), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Cerebrovascular Accident |
| Intervention type | Drug |
| Interventions | Reopro, Retrovase |
| Enrollment | 72 |
| Start date | Sep 24, 2002 |
| Primary completion | Jul 20, 2007 |
| Completion | Jul 20, 2007 |
| First posted | Sep 26, 2002 |
| Last update posted | Jul 2, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: